Chemokine Therapeutics Corp. Closes $885,000 Offering

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 16, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced that it has closed, via a non-brokered private placement, an offering of approximately 5,900,000 units at a price of $0.15 per unit for gross proceeds to the Company of approximately $885,000 (the "Offering").

Back to news